These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 24911644

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of the effects of reuptake and hydrolysis inhibition on interstitial endocannabinoid levels in the brain: an in vivo microdialysis study.
    Wiskerke J, Irimia C, Cravatt BF, De Vries TJ, Schoffelmeer AN, Pattij T, Parsons LH.
    ACS Chem Neurosci; 2012 May 16; 3(5):407-17. PubMed ID: 22860210
    [Abstract] [Full Text] [Related]

  • 4. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
    Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, Jin X, Burston JJ, Sim-Selley LJ, Lichtman AH, Wiley JL, Cravatt BF.
    Proc Natl Acad Sci U S A; 2009 Dec 01; 106(48):20270-5. PubMed ID: 19918051
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
    Walentiny DM, Vann RE, Wiley JL.
    Neuropharmacology; 2015 Jun 01; 93():237-42. PubMed ID: 25698527
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors.
    Bedse G, Bluett RJ, Patrick TA, Romness NK, Gaulden AD, Kingsley PJ, Plath N, Marnett LJ, Patel S.
    Transl Psychiatry; 2018 Apr 26; 8(1):92. PubMed ID: 29695817
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model.
    Adamson Barnes NS, Mitchell VA, Kazantzis NP, Vaughan CW.
    Br J Pharmacol; 2016 Jan 26; 173(1):77-87. PubMed ID: 26398331
    [Abstract] [Full Text] [Related]

  • 11. Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.
    Limebeer CL, Abdullah RA, Rock EM, Imhof E, Wang K, Lichtman AH, Parker LA.
    Psychopharmacology (Berl); 2014 Feb 26; 231(3):603-12. PubMed ID: 24043345
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
    Kinsey SG, O'Neal ST, Long JZ, Cravatt BF, Lichtman AH.
    Pharmacol Biochem Behav; 2011 Mar 26; 98(1):21-7. PubMed ID: 21145341
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endocannabinoid degradation inhibitors ameliorate neuronal and synaptic alterations following traumatic brain injury.
    Fucich EA, Stielper ZF, Cancienne HL, Edwards S, Gilpin NW, Molina PE, Middleton JW.
    J Neurophysiol; 2020 Feb 01; 123(2):707-717. PubMed ID: 31913777
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.
    Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pavón FJ, Serrano AM, Selley DE, Parsons LH, Lichtman AH, Cravatt BF.
    Nat Chem Biol; 2009 Jan 01; 5(1):37-44. PubMed ID: 19029917
    [Abstract] [Full Text] [Related]

  • 20. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
    Kinsey SG, Long JZ, O'Neal ST, Abdullah RA, Poklis JL, Boger DL, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2009 Sep 01; 330(3):902-10. PubMed ID: 19502530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.